Eikrem Oystein, Beisland Christian, Hjelle Karin, Flatberg Arnar, Scherer Andreas, Landolt Lea, Skogstrand Trude, Leh Sabine, Beisvag Vidar, Marti Hans-Peter
Department of Clinical Medicine, Nephrology, University of Bergen, Bergen, Norway.
Department of Clinical Medicine, Urology, University of Bergen, Bergen, Norway.
PLoS One. 2016 Feb 22;11(2):e0149743. doi: 10.1371/journal.pone.0149743. eCollection 2016.
Formalin-fixed, paraffin-embedded (FFPE) tissues are an underused resource for molecular analyses. This proof of concept study aimed to compare RNAseq results from FFPE biopsies with the corresponding RNAlater® (Qiagen, Germany) stored samples from clear cell renal cell carcinoma (ccRCC) patients to investigate feasibility of RNAseq in archival tissue. From each of 16 patients undergoing partial or full nephrectomy, four core biopsies, such as two specimens with ccRCC and two specimens of adjacent normal tissue, were obtained with a 16g needle. One normal and one ccRCC tissue specimen per patient was stored either in FFPE or RNAlater®. RNA sequencing libraries were generated applying the new Illumina TruSeq® Access library preparation protocol. Comparative analysis was done using voom/Limma R-package. The analysis of the FFPE and RNAlater® datasets yielded similar numbers of detected genes, differentially expressed transcripts and affected pathways. The FFPE and RNAlater datasets shared 80% (n = 1106) differentially expressed genes. The average expression and the log2 fold changes of these transcripts correlated with R2 = 0.97, and R2 = 0.96, respectively. Among transcripts with the highest fold changes in both datasets were carbonic anhydrase 9 (CA9), neuronal pentraxin-2 (NPTX2) and uromodulin (UMOD) that were confirmed by immunohistochemistry. IPA revealed the presence of gene signatures of cancer and nephrotoxicity, renal damage and immune response. To simulate the feasibility of clinical biomarker studies with FFPE samples, a classifier model was developed for the FFPE dataset: expression data for CA9 alone had an accuracy, specificity and sensitivity of 94%, respectively, and achieved similar performance in the RNAlater dataset. Transforming growth factor-ß1 (TGFB1)-regulated genes, epithelial to mesenchymal transition (EMT) and NOTCH signaling cascade may support novel therapeutic strategies. In conclusion, in this proof of concept study, RNAseq data obtained from FFPE kidney biopsies are comparable to data obtained from fresh stored material, thereby expanding the utility of archival tissue specimens.
福尔马林固定、石蜡包埋(FFPE)组织是一种未得到充分利用的分子分析资源。这项概念验证研究旨在比较FFPE活检组织与相应的来自透明细胞肾细胞癌(ccRCC)患者的储存在RNAlater®(德国Qiagen公司)中的样本的RNA测序结果,以研究在存档组织中进行RNA测序的可行性。从16例接受部分或全肾切除术的患者中,用16g针获取四个核心活检样本,如两个ccRCC标本和两个相邻正常组织标本。每位患者的一个正常组织和一个ccRCC组织标本分别储存在FFPE或RNAlater®中。应用新的Illumina TruSeq® Access文库制备方案生成RNA测序文库。使用voom/Limma R包进行比较分析。对FFPE和RNAlater®数据集的分析产生了相似数量的检测到的基因、差异表达的转录本和受影响的途径。FFPE和RNAlater数据集共享80%(n = 1106)的差异表达基因。这些转录本的平均表达和log2倍变化的相关性分别为R2 = 0.97和R2 = 0.96。在两个数据集中具有最高倍变化的转录本中,有碳酸酐酶9(CA9)、神经元五聚体蛋白2(NPTX2)和尿调节蛋白(UMOD),它们通过免疫组织化学得到了证实。IPA揭示了癌症、肾毒性、肾损伤和免疫反应的基因特征的存在。为了模拟使用FFPE样本进行临床生物标志物研究的可行性,为FFPE数据集开发了一个分类模型:单独CA9的表达数据的准确性、特异性和敏感性分别为94%,并且在RNAlater数据集中表现相似。转化生长因子-β1(TGFB1)调节的基因、上皮-间质转化(EMT)和NOTCH信号级联可能支持新的治疗策略。总之,在这项概念验证研究中,从FFPE肾活检组织获得的RNA测序数据与从新鲜储存材料获得的数据具有可比性,从而扩大了存档组织标本的用途。